Singapore markets closed

Blueprint Medicines Corporation (BPMC)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
105.92+11.06 (+11.65%)
As of 11:15AM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts15151515
Avg. Estimate-1.66-1.48-5.56-2.78
Low estimate-1.8-1.63-6.39-6.46
High estimate-1.46-1.22-4.37-0.27
Year ago EPS-2.15-2.19-8.37-5.56
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts15151717
Avg. Estimate80.43M93.04M392.12M594.62M
Low estimate65M87M372M481.18M
High estimate86.7M103M449M738.9M
Year ago sales63.29M45.47M249.38M392.12M
Sales growth (year/est)27.10%104.60%57.20%51.60%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-2.67-2.54-2.37-2.04
Actual EPS-2.15-2.19-2.2-1.82
Difference0.520.350.170.22
Surprise %19.50%13.80%7.20%10.80%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-1.66-1.48-5.56-2.78
7 days ago-1.66-1.48-5.55-2.78
30 days ago-1.66-1.48-5.55-2.78
60 days ago-1.67-1.48-5.55-2.78
90 days ago-1.73-1.45-5.39-2.98
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 days1N/AN/A1
Up last 30 days3122
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/A1N/A
Growth estimatesBPMCIndustrySector(s)S&P 500
Current qtr.22.80%N/AN/AN/A
Next qtr.32.40%N/AN/AN/A
Current year33.60%N/AN/AN/A
Next year50.00%N/AN/AN/A
Next 5 years (per annum)-92.01%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A